Global Retirement Partners’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $140K | Buy |
+4,139
| New | +$138K | ﹤0.01% | 1822 |
|
|
2025
Q4 | $42.4K | Buy |
1,360
+292
| +27% | +$7.19K | ﹤0.01% | 2454 |
|
|
2025
Q3 | $21.6K | Sell |
1,068
-548
| -34% | -$9.63K | ﹤0.01% | 2361 |
|
|
2025
Q2 | $27.1K | Buy |
+1,616
| New | +$26.1K | ﹤0.01% | 2120 |
|
|
2024
Q4 | $58.8K | Sell |
2,667
-2,285
| -46% | -$41.6K | ﹤0.01% | 1546 |
|
|
2024
Q3 | $89.2K | Buy |
4,952
+1,911
| +63% | +$33.4K | ﹤0.01% | 1292 |
|
|
2024
Q2 | $49.4K | Buy |
3,041
+2,365
| +350% | +$36.4K | ﹤0.01% | 1541 |
|
|
2024
Q1 | $9.54K | Buy |
676
+261
| +63% | +$3.29K | ﹤0.01% | 2147 |
|
|
2023
Q4 | $4.57K | Hold |
415
| – | – | ﹤0.01% | 2355 |
|
|
2023
Q3 | $3.81K | Hold |
415
| – | – | ﹤0.01% | 2285 |
|
|
2023
Q2 | $3.13K | Hold |
415
| – | – | ﹤0.01% | 2380 |
|
|
2023
Q1 | $3.65K | Hold |
415
| – | – | ﹤0.01% | 2279 |
|
|
2022
Q4 | $3.79K | Buy |
415
+327
| +372% | +$2.85K | ﹤0.01% | 2118 |
|
|
2022
Q3 | $1K | Sell |
88
-5
| -5% | -$44 | ﹤0.01% | 2592 |
|
|
2022
Q2 | $1K | Hold |
93
| – | – | ﹤0.01% | 2564 |
|
|
2022
Q1 | $1K | Buy |
+93
| New | +$776 | ﹤0.01% | 2523 |
|
|
2021
Q4 | – | Sell |
-178
| Closed | -$2K | – | 1632 |
|
|
2021
Q3 | $2K | Buy |
178
+129
| +263% | +$1.21K | ﹤0.01% | 1852 |
|
|
2021
Q2 | $0 | Hold |
49
| – | – | ﹤0.01% | 1939 |
|
|
2021
Q1 | $1K | Sell |
49
-1,000
| -95% | -$11.5K | ﹤0.01% | 1743 |
|
|
2020
Q4 | $10K | Buy |
1,049
+1,000
| +2,041% | +$9.58K | ﹤0.01% | 1273 |
|
|
2020
Q3 | $0 | Sell |
49
-20
| -29% | -$212 | ﹤0.01% | 1717 |
|
|
2020
Q2 | $1K | Hold |
69
| – | – | ﹤0.01% | 1565 |
|
|
2020
Q1 | $1K | Hold |
69
| – | – | ﹤0.01% | 1529 |
|
|
2019
Q4 | $1K | Hold |
69
| – | – | ﹤0.01% | 1569 |
|
|
2019
Q3 | $0 | Hold |
69
| – | – | ﹤0.01% | 1680 |
|
|
2019
Q2 | $1K | Hold |
69
| – | – | ﹤0.01% | 1548 |
|
|
2019
Q1 | $1K | Hold |
69
| – | – | ﹤0.01% | 1486 |
|
|
2018
Q4 | $1K | Buy |
69
+49
| +245% | +$1K | ﹤0.01% | 1418 |
|
|
2018
Q3 | $0 | Sell |
20
-200
| -91% | -$4.64K | ﹤0.01% | 1577 |
|
|
2018
Q2 | $5K | Buy |
220
+200
| +1,000% | +$4.08K | ﹤0.01% | 1209 |
|
|
2018
Q1 | $0 | Sell |
20
-112
| -85% | -$2.19K | ﹤0.01% | 1536 |
|
|
2017
Q4 | $3K | Hold |
132
| – | – | ﹤0.01% | 1253 |
|
|
2017
Q3 | $2K | Buy |
132
+92
| +230% | +$2.07K | ﹤0.01% | 1140 |
|
|
2017
Q2 | $1K | Buy |
+40
| New | +$1.24K | ﹤0.01% | 1115 |
|
Other funds holding TEVA
HIIFS
PF
CI
MMH
MIFH
LIM
Global Retirement Partners's TEVA Position: Q2 2026 in Review
Global Retirement Partners opened a new position in Teva Pharmaceuticals (TEVA) in Q2 2026: 4,139 shares worth $140K. The stake represents ﹤0.01% of the portfolio and ranks #1822 among its holdings. This is a return to the name: Global Retirement Partners previously reported a position in TEVA as recently as Q4 2025.
Global Retirement Partners first reported a position in TEVA in Q2 2017 and has held it in 34 quarters since. 672 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.
- Global Retirement Partners held 4,139 shares of Teva Pharmaceuticals worth $140K as of Q2 2026.
- Teva Pharmaceuticals was a new Global Retirement Partners position in Q2 2026.
- Teva Pharmaceuticals made up ﹤0.01% of Global Retirement Partners's portfolio in Q2 2026, its #1822 holding.
- Global Retirement Partners first reported a position in Teva Pharmaceuticals in Q2 2017 and has held it in 34 quarters since.
- 672 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.
Based on Global Retirement Partners's 13F filing for Q2 2026, filed 6 Aug 2026.